Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

David H Ilson, MD, discusses thoughts on PEG IL-10 and PEGPH20 studies presented at ASCO GI

Dr. Ilson, Memorial Sloan Kettering Cancer Center, shares thoughts on the clinical trial results of PEG IL-10 and PEGPH20 studies in pancreas cancer presented at ASCO GI 2020

Tags: Pancreatic

Published: 31 January 2020

Recent Videos: Pancreatic

There have been no new videos in this category within the last 12 months.

Related Videos

video-image

Eileen O'Reilly, MD, shares outcomes of the POLO study and its importance to physicians

video-image

Eileen O'Reilly, MD, describes how physicians should test for BRCA in pancreatic cancer patients

video-image

Irvin Modlin, MD, on when to use NETest clinically and situations it has clinical utility

video-image

Philip Philip, MD, on the phase 2 study comparing chemo with or without veliparib in pancreas

video-image

Philip Philip, MD, shares opinion on treatment of a BRCA+ pancreatic cancer patient

video-image

Philip Philip, MD, explains how physicians should test for BRCA in pancreatic cancer patients

video-image

Philip Philip, MD, on the outcomes of the POLO study and its importance to physicians

video-image

Philip Philip, MD, provides thoughts on the role of PARP inhibitors in advanced pancreatic cancer

video-image

Eileen O'Reilly, MD, on the phase 2 study comparing chemo with or without veliparib in pancreas

video-image

Eileen O'Reilly, MD, provides evidence to inform treatment of pancreatic cancer patients

video-image

Philip Philip MD, PhD, FRCP, on the APACT trial in surgically resected pancreatic adenocarcinoma

video-image

Vincent Chung, MD, shares details from the APACT study in pancreatic adenocarcinoma

video-image

Josep Tabernero, MD, PhD, provides perspective on the POLO trial in pancreatic

video-image

Philip Philip MD, PhD, FRCP, on BRCA gene mutations & outcomes in pancreatic cancer

video-image

Vincent Chung, MD, elaborates on BRCA mutations and pancreatic cancer

video-image

Philip Philip MD, PhD, FRCP, discusses outcomes from the POLO trial in pancreatic cancer

video-image

Vincent Chung, MD, shares outcomes from the POLO trial metastatic pancreatic cancer

video-image

Leonard Saltz, MD, shares outcomes from the APACT trial in pancreatic adenocarcinoma

video-image

Talia Golan, MD, explains the role of biomarkers in the treatment of pancreatic cancer

video-image

Talia Golan, MD, regarding the practice-changing potential of the POLO trial

video-image

Thomas A. Abrams, MD, elaborates on the outcomes from the APACT study

video-image

Talia Golan, MD, elaborates on the outcomes from the POLO study presented at ASCO 2019

video-image

Thomas A. Abrams, MD, provides perspective on the POLO trial in metastatic pancreatic cancer

video-image

John Strickler, MD, shares thoughts on molecular subtyping of pancreatic cancer

video-image

Zev Wainberg, MD, on checkpoint inhibition with chemotherapy in pancreatic cancer

video-image

Bassel El-Reyes, MD, speculates on promising novel therapies being developed for pancreatic cancer

video-image

Bassel El-Reyes, MD, considers upfront surgery for resectable pancreatic cancer

video-image

Bassel El-Reyes, MD, offers his opinion on NGS & BRCA gene testing for pancreatic cancer

video-image

Bassel El-Reyes, MD, regarding molecular subtyping of pancreatic cancer

video-image

Rachna Shroff, MD, gives her take on pre-operative therapy in resectable pancreatic cancer

video-image

Philip Philip MD, PhD, FRCP, on promising novel therapies for pancreatic cancer

video-image

Philip Philip MD, PhD, FRCP, provides opinion on NGS and BRCA gene testing in pancreatic cancer

video-image

Philip Philip MD, PhD, FRCP, considers molecular subtyping of pancreatic cancer

video-image

Philip Philip MD, PhD, FRCP, on screening patients at high risk for pancreatic cancer

video-image

John Leighton, MD, regarding preoperative chemotherapy in resectable pancreatic cancer

video-image

John Leighton, MD, regarding the PA.6 clinical study presented at ASCO 2018

video-image

James A. Posey III, MD, on the outcomes of the LAPACT study in locally advanced pancreatic cancer

video-image

James A. Posey III, MD, comments on the impact of immunotherapy agents in pancreatic cancer

video-image

James A. Posey III, MD, discusses the unmet medical needs in pancreatic ductal adenocarcinoma

video-image

James A. Posey III, MD, offers opinion on preoperative chemotherapy in resectable pancreatic cancer

video-image

James A. Posey III, MD, on the results and implications of the PA.6 clinical trial from ASCO 2018

video-image

Richard Goldberg, MD, on how the FIRE-3 data in CRC presented at ASCO 2018 reinforces CALGB 80405

video-image

Richard Goldberg, MD, considers the value of preoperative chemotherapy in pancreatic cancer

video-image

Richard Goldberg, MD, regarding the outcomes of the PA.6 clinical study in pancreatic cancer

video-image

Al Benson III, MD, FACP, tells us about the outcomes of the ECOG-ACRIN study

video-image

Philip Philip, MD, PhD, FRCP, on the implications of the LAPACT study presented at ASCO 2018

video-image

Philip Philip, MD, PhD, FRCP, considers the impact of immunotherapy agents in pancreatic cancer

video-image

Philip Philip, MD, PhD, FRCP, regarding key unmet needs in pancreatic ductal adenocarcinoma

video-image

Philip Philip, MD, reflects on the impact of PEGPH20 in met pancreatic cancer

video-image

Philip Philip, MD, talks about treating a newly diagnosed stage 4 pancreatic cancer patient

video-image

Philip Philip, MD, on whether resected pancreatic cancer patients should be offered adjuvant therapy

video-image

Richard M. Goldberg, MD, FASCO on adjuvant pancreatic cancer news

video-image

Pancreatic Cancer News from ASCO GI 2016